Sfoglia per Autore
Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
2020-01-01 Ferraris, Chiara; Cavalli, Roberta; Panciani, Pier Paolo; Battaglia, Luigi
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment
2020-01-01 Dianzani C.; Monge C.; Miglio G.; Serpe L.; Martina K.; Cangemi L.; Ferraris C.; Mioletti S.; Osella S.; Gigliotti C.L.; Boggio E.; Clemente N.; Dianzani U.; Battaglia L.
Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM)
2021-01-01 Perrelli A.; Fatehbasharzad P.; Benedetti V.; Ferraris C.; Fontanella M.; De Luca E.; Moglianetti M.; Battaglia L.; Retta S.F.
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms
2021-01-01 Muntoni E.; Anfossi L.; Milla P.; Marini E.; Ferraris C.; Capucchio M.T.; Colombino E.; Segale L.; Porta M.; Battaglia L.
Nanosystems in cosmetic products: A brief overview of functional, market, regulatory and safety concerns
2021-01-01 Ferraris C.; Rimicci C.; Garelli S.; Ugazio E.; Battaglia L.
Formulations of highly antiproliferative hydrophobic Pt(IV) complexes into lipidic nanoemulsions as delivery vehicles
2022-01-01 Gabano E.; Ferraris C.; Osella D.; Battaglia L.S.; Ravera M.
Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations
2022-01-01 Muntoni E.; Marini E.; Ferraris C.; Garelli S.; Capucchio M.T.; Colombino E.; Panciani P.P.; Battaglia L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours | 2020 | Ferraris, Chiara; Cavalli, Roberta; Panciani, Pier Paolo; Battaglia, Luigi | |
| Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment | 2020 | Dianzani C.; Monge C.; Miglio G.; Serpe L.; Martina K.; Cangemi L.; Ferraris C.; Mioletti S.; Osella S.; Gigliotti C.L.; Boggio E.; Clemente N.; Dianzani U.; Battaglia L. | |
| Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM) | 2021 | Perrelli A.; Fatehbasharzad P.; Benedetti V.; Ferraris C.; Fontanella M.; De Luca E.; Moglianetti M.; Battaglia L.; Retta S.F. | |
| Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms | 2021 | Muntoni E.; Anfossi L.; Milla P.; Marini E.; Ferraris C.; Capucchio M.T.; Colombino E.; Segale L.; Porta M.; Battaglia L. | |
| Nanosystems in cosmetic products: A brief overview of functional, market, regulatory and safety concerns | 2021 | Ferraris C.; Rimicci C.; Garelli S.; Ugazio E.; Battaglia L. | |
| Formulations of highly antiproliferative hydrophobic Pt(IV) complexes into lipidic nanoemulsions as delivery vehicles | 2022 | Gabano E.; Ferraris C.; Osella D.; Battaglia L.S.; Ravera M. | |
| Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations | 2022 | Muntoni E.; Marini E.; Ferraris C.; Garelli S.; Capucchio M.T.; Colombino E.; Panciani P.P.; Battaglia L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile